Dietary Supplements and Nutraceuticals Under Investigation for COVID-19 Prevention and Treatment
AI-generated Key Points
- COVID-19 pandemic has caused widespread disruption and loss of life
- Interest in exploring dietary supplements and nutraceuticals for prevention and treatment of COVID-19
- Products under investigation include vitamin C, vitamin D, omega 3 fatty acids, probiotics, and zinc
- Nutritional status plays a crucial role in patient outcomes
- Vitamin D deficiency may be associated with higher incidence of infection and more severe cases of COVID-19
- Research on dietary supplements and nutraceuticals is still in early stages
- Scientific organizations considering recommending certain supplements like vitamin D to those at risk but guidelines are yet to be established
- Further study is required before definitive conclusions can be drawn on the effectiveness of these products for COVID-19 prevention and treatment
- Individuals seeking information related to COVID-19 should consult reliable sources such as local health departments or official guidance from organizations like the CDC or their respective governments
Authors: Ronan Lordan, Halie M. Rando, COVID-19 Review Consortium, Casey S. Greene
Abstract: Coronavirus disease 2019 (COVID-19) has caused global disruption and a significant loss of life. Existing treatments that can be repurposed as prophylactic and therapeutic agents could reduce the pandemic's devastation. Emerging evidence of potential applications in other therapeutic contexts has led to the investigation of dietary supplements and nutraceuticals for COVID-19. Such products include vitamin C, vitamin D, omega 3 polyunsaturated fatty acids, probiotics, and zinc, all of which are currently under clinical investigation. In this review, we critically appraise the evidence surrounding dietary supplements and nutraceuticals for the prophylaxis and treatment of COVID-19. Overall, further study is required before evidence-based recommendations can be formulated, but nutritional status plays a significant role in patient outcomes, and these products could help alleviate deficiencies. For example, evidence indicates that vitamin D deficiency may be associated with greater incidence of infection and severity of COVID-19, suggesting that vitamin D supplementation may hold prophylactic or therapeutic value. A growing number of scientific organizations are now considering recommending vitamin D supplementation to those at high risk of COVID-19. Because research in vitamin D and other nutraceuticals and supplements is preliminary, here we evaluate the extent to which these nutraceutical and dietary supplements hold potential in the COVID-19 crisis.
Ask questions about this paper to our AI assistant
You can also chat with multiple papers at once here.
Assess the quality of the AI-generated content by voting
Score: 0
Why do we need votes?
Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.
The previous summary was created more than a year ago and can be re-run (if necessary) by clicking on the Run button below.
Similar papers summarized with our AI tools
Navigate through even more similar papers through a
tree representationLook for similar papers (in beta version)
By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.
Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.